Related Experiment Video
Updated: May 31, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Exploring the Involvement of New Members of the Interleukin Family in Cardiovascular Disease
Abdullah Al Noman1, Sanzida Alam Flora1, Monty Datta2
1School of Pharmacy, BRAC University, Dhaka 1212, Bangladesh.
Insights
Newer interleukins, including IL-27, IL-31, IL-32, IL-33, and the IL-28 group, are increasingly linked to cardiovascular diseases (CVD). Understanding their roles offers potential new therapeutic targets for heart conditions.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases (CVD) are a leading global cause of mortality.
- While some interleukins are known CVD factors, novel members of this family are emerging as significant players.
- Recent research highlights specific interleukins' potential impact on cardiovascular health and disease.
Purpose of the Study:
- To review the current understanding of recently identified interleukins in cardiovascular disease development.
- To explore the mechanisms and implications of interleukins like IL-27, IL-31, IL-32, IL-33, and the IL-28 group in CVD.
Main Methods:
- Literature review synthesizing current research on novel interleukins and CVD.
- Analysis of interleukin-specific receptors, signaling pathways, and their effects on inflammation and vascular function.
Main Results:
- IL-27 may reduce inflammation in atherosclerosis by controlling Th17 cell development.
- IL-31 is implicated in neuro-immune interactions and pruritus, with potential CVD relevance.
- IL-32 promotes inflammatory protein generation and is linked to coronary artery disease.
- IL-33 demonstrates cardioprotective effects; its decoy receptor sST2 may serve as a biomarker.
- The IL-28 group's antiviral and immune-modulating roles in CVD require further investigation.
Conclusions:
- Novel interleukins play diverse roles in cardiovascular disease pathogenesis through distinct pathways.
- Elucidating these cytokine interactions can reveal new therapeutic targets for CVD prevention and treatment.
- Further research is essential to understand how these interleukins engage with established CVD pathways.
Abstract:
Cardiovascular diseases remain a significant reason for illness and death globally. Although certain interleukins have been extensively researched about cardiovascular disease (CVD), new findings have identified unique members of the interleukin family that could potentially play a role in cardiovascular well-being and ailments. This review discusses the current understanding of the role of these recently identified interleukins, such as IL-27, IL-31, IL-32, IL-33, and the IL-28 group (IL-28A, IL-28B, IL-29), in the development of cardiovascular diseases. Every interleukin has various impacts achieved through particular receptors and signaling pathways that affect inflammatory processes, differentiation of immune cells, and the functioning of blood vessels. IL-27 controls the development of inflammatory Th17 cells and might decrease inflammation in atherosclerosis. IL-31 plays a role in the interaction between the immune system and nerves, as well as in itching. IL-32 enhances the generation of inflammatory proteins and has been linked to coronary artery disease. IL-33 has beneficial effects on the cardiovascular system, whereas its imitation receptor sST2 could potentially be used as a biomarker. Additional studies are needed to investigate the antiviral and immune-system regulating effects of the IL-28 group in cardiovascular diseases. In general, explaining the ways in which new interleukins contribute to the progression of cardiovascular diseases can help discover fresh targets for therapy and new approaches toward enhancing the prevention and treatment of heart disorders. Additional research on the way these cytokines engage with established disease pathways is necessary.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Inflammation
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

